IFARMA works on issues of access, use, and quality of medicines in Colombia, striving to ensure equitable and affordable treatment for all.
Since 1993, IFARMA has played a key role in Colombia’s public health landscape. Their strong relationships with civil society groups and government institutions, including the National University of Colombia, have positioned them as a vital contributor to medicine access policy. They have engaged in the development of national policies on hepatitis prevention and treatment, biosimilars legislation, and advocacy for compulsory licensing.
IFARMA has documented and supported campaigns for compulsory licenses and continues to leverage its knowledge of Colombia’s local manufacturing landscape to promote domestic production of vaccines and medicines.